Learning Objectives:

  • To understand the process of developing a first-in-class drug
  • To evaluate the potential of siRNA therapeutics in cancer
  • To understand mechanisms of resistance
Session date: 
06/24/2024 - 12:00pm to 1:00pm CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
James Brugarolas, MD, PhD